Importance Effective prevention strategies for HIV infection are an important public health
priority. Preexposure prophylaxis (PrEP) involves use of antiretroviral therapy (ART) daily or …

Introduction Oral pre-exposure prophylaxis (PrEP) is an effective strategy to reduce the risk
of HIV transmission in high risk individuals. However, the effectiveness of oral pre-exposure …

Introduction Stigma and disclosure concerns have been key barriers to oral pre‐exposure
prophylaxis (PrEP) adherence for African adolescent girls and young women (AGYW) in …

Background: Antiretroviral pre-exposure prophylaxis (PrEP) is a novel HIV prevention
strategy for which adherence is a known determinant of efficacy. Blood concentrations of …

To date, six clinical trials have explored the efficacy of pre-exposure prophylaxis (PrEP)
against HIV infection using oral tenofovir and/or emtricitabine/tenofovir [1–6]. Efficacy ranged …

Importance A 2019 review for the US Preventive Services Task Force (USPSTF) found oral
preexposure prophylaxis (PrEP) associated with decreased HIV infection risk vs placebo or …

Adherence to daily oral antiretroviral therapy (ART) is a barrier to both treatment and
prevention of human immunodeficiency virus (HIV) infection. To overcome limitations of life …

Introduction Despite the efficacy of pre‐exposure prophylaxis (PrEP) in preventing HIV
transmission, few studies have evaluated PrEP use and retention in care outcomes in real …

Background Antiretroviral-based interventions for HIV-1 prevention, including antiretroviral
therapy (ART) to reduce the infectiousness of HIV-1 infected persons and pre-exposure …

Regimen adherence remains a major hurdle to the success of daily oral drug regimens for
the treatment and prevention of human immunodeficiency virus (HIV) infection. Long-acting …